The Dosing-Ttme Dependent Influence of Chronic Cyclosporin a Treatment on Daily Profiles of Plasma Glucose and Insulin in the Wistar Rat

References

• Bani-Sacchi T, Bani D, Filipponi F, Michel A, Houssin D. Immunocytochemical and ultrastructural changes of islet cells in rats treated long term with cyclosporine at immunotherapeutic doses. Transplantation 1990; 49: 982–87
   PubMed Web of Science ®Google Scholar
• Robertson R P. Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells. Diabetes 1986; 35: 1016–19
   PubMed Web of Science ®Google Scholar
• Nielsen J H, Mandrup-Poulsen T, Nerup J. Direct effects of cyclosporin A on human pancreatic B-cells. Diabetes 1986; 35: 1049–52
   PubMed Web of Science ®Google Scholar
• Yale J F, Roy R D, Grose M, Seemayer A, Murphy G F, Marliss E B. Effects of cyclosporine on glucose tolerance in the rat. Diabetes 1985; 34: 1309–13
   PubMed Web of Science ®Google Scholar
• Hahn H J, Laube R, Lucke S, Besch W. Alteration of pancreatic B-cells in Wistar rats treated with non-diabetogenic doses of cyclosporin A. Pharmacol Toxicol 1992; 70: 188–91
   PubMedGoogle Scholar
• Canafax D M, Cipolle R J, Hrushesky W JM, Rabatin J T, Min D I, Graves N M, Sutherland D ER, Bowers L D. Increased evening exposure to cyclosporine and metabolites. Annu Rev Chronopharmacol 1988; 5: 5–8
   Google Scholar
• Ramon M, Morel D, Penouil F, Grellet J, Potaux L, Saux M C, Brachet-Liermain A. Variations nycthémérales de la ciclosporine administrée par voie orale à des transplantés rénaux. Therapie 1989; 44: 371–74
   PubMedGoogle Scholar
• Sabate I, Grino J M, Castelao A M, Arranz B, Gonzales C, Guillén E, Diaz C, Hu-Guet J, Gracia S. Diurnal variations of cyclosporine and metabolites in renal transplant patients. Transplant Proceed 1990; 22: 1700–1
   PubMed Web of Science ®Google Scholar
• Malmary M F, Kabbaj K, Labat C, Batalla A, Houti I, Moussamih S, Oustrin J. Chronopharmacokinetics of cyclosporine A in the Wistar rat following oral administration. Eur J Drug Metabol Pharmacokin 1992; 17: 135–44
   PubMed Web of Science ®Google Scholar
• Reinberg A. Clinical chronopharmacology. An experimental basis for chronother-apy. Biological rhythms and medicine. Cellular, metabolic, physiopathologic and pharmacologic aspects, A Reinberg, M H Smolensky. Springer-Verlag, Berlin 1983; 211–64
   Google Scholar
• Méjean L, Bicakova-Rocher A, Kolopp M, Villaume C, Levi F, Debry G, Reinberg A, Drouin P. Orcadian and ultradian rhythms in blood glucose and plasma insulin of healthy subjects. Chronobiol Internal 1988; 5: 227–36
   PubMed Web of Science ®Google Scholar
• Mejean L, Kolopp M, Drouin P. Chronobiology, nutrition and diabetes mellitus. Biologic rhythms in clinical and laboratory medicine, Y Touitou, E Haus. Springer-Verlag, Berlin 1992; 375–85
   Google Scholar
• Lévi F, Roulon A. Chronobioiogie et expérimentation animale: aspects appliqués à la chronopharmacologie des cytostatiques. Sci Tech Anim Lab 1989; 14: 103–18
   Google Scholar
• Kahn G C, Shaw L M, Kane M D. Routine monitoring of cyclosporine in whole blood and in kidney tissue using high performance liquid chromatography. J Anal Toxicol 1988; 10: 28–34
   Web of Science ®Google Scholar
• Van den Berg J WO, Verhoef M L, De Boer A, Schalm S W. Cyclosporin A assay: conditions for sampling and processing of blood. Clin Chem Acta 1985; 147: 291–97
   PubMed Web of Science ®Google Scholar
• Pessacq M T, Rebolledo O R, Mercier R G, Gagliardino J J. Effects of fasting on the circadian rhythm of serum insulin levels. Diabetes Care 1976; 3: 20–26
   Google Scholar
• Yamamoto H, Nagai K, Nakagawa H. Role of SNC in daily rhythm of plasma glucose, FFA, insulin and glucagon. Chronobiol lnternat 1987; 4: 483–91
   PubMed Web of Science ®Google Scholar
• Gagliardino J J, Hernandez R E, Rebolledo O R. Chronobiological aspects of blood glucose regulation: a new scope for the study of diabetes mellitus. Chronobiologia 1984; 11: 357–79
   PubMedGoogle Scholar
• Gunnarson R, Lundorin G, Whezer H, Ostman J, Groth C G. Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporin. Lancet 1983; 2: 571–72
   PubMed Web of Science ®Google Scholar
• Lanzer G, Beaufort F, Kolb H, Semmelrock H J, Ziak E, Borkenstein J, Zeichen R, Pogglistch H. Cyclosporin A as diabetogen kofactor. WMW 1986; 21–2: 557–59
   Google Scholar
• Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Postransplant hyperglycemia. Transplantation 1989; 47: 278–81
   PubMed Web of Science ®Google Scholar
• Bending J J, Ogg C S, Viberti G C. Diabetogenic effect of cyclosporin. Brit Med J 1987; 294: 401–2
   PubMed Web of Science ®Google Scholar
• Hahn H J, Kauert C, Kotzke G. Induction of a diabetes-like syndrome by cyclosporine in Wistar rats and its reversibility after drug withdrawal. Exp Clin Endocrinol 1987; 90: 46–50
   PubMedGoogle Scholar
• Healey M A, Clas D, Duguid W P, Rosenberg L. Adverse effects of cyclosporine on islet growth and differentiation. J Surg Res 1990; 48: 557–61
   PubMed Web of Science ®Google Scholar
• Van Schilfgaarde R, Van der Burg M PM, Van Suylichem P TR, Frolich M, Gooszen H G, Moolenaar A J. Interference by cyclosporine with the endocrine function of the canine pancreas. Transplantation 1987; 44: 13–16
   PubMed Web of Science ®Google Scholar
• Malmary M F, Kabbaj K, Oustrin J. Circadian dosing-stage dependence in metabolic effects of cyclosporine in the rat. Annu Rev Chronopharmacol 1988; 5: 35–38
   Google Scholar
• Eun H M, Pak C Y, Kim C J, McArthur R G, Yoon J W. Role of cyclosporin A in macromolecular synthesis of B-cells. Diabetes 1987; 36: 952–58
   PubMed Web of Science ®Google Scholar
• Papaccio G, Esposito V, Mezzogiorno V. Recovery of pancreatic B-cells after cyclosporin A treatment in Bio Breeding and Wistar rats. Micron Microsc Acta 1989; 20: 89–97
   Web of Science ®Google Scholar
• Jablenska R, Ogneva V, Petkov P. Effects of cyclosporin A on the endocrine pancreas of the rat. Morphological and immunohistochemical studies. Acta Diabet Lat 1989; 26: 43–49
   PubMedGoogle Scholar
• Mason J. Pharmacology of cyclosporine (Sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol Rev 1989; 42: 423–34
   Google Scholar
• Assimacopoulos-Jeannet F, Jeanrenaud B. Contröle du transport du glucose par l'insuline. Med Sci 1989; 5: 33–41
   Google Scholar
• Akagi H, Reynolds A, Hjelm M. Cyclosporin A and its metabolites, distribution in blood and tissues. J Intern Med Res 1991; 19: 1–18
   PubMed Web of Science ®Google Scholar